IDH2 and central nervous system cancer: Genetically similar stem-like cell populations have been identified in IDH-mutant gliomas (Venteicher et al., 2017; Tirosh et al., 2016) supporting the notion that epigenetic reprogramming induced by IDH mutations contributes to a differentiation block (Lu et al., 2012).